SeaStar Medical Holding Corporation (ICU )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ICU
- Company SeaStar Medical Holding Corporation
- Price $0.32
- Changes Percentage -16.65
- Change -0.0633
- Day Low $0.31
- Day High $0.4
- Year High $3.07
- Year Low $0.31
- Market Cap $8,761,453
- Price Avg 50 EMA (D) $0.67
- Price Avg 200 EMA (D) $1.09
- Exchange NASDAQ
- Volume 1,847,563
- Average Volume 1,957,114
- Open $0.4
- Previous Close $0.38
- EPS -1.85
- PE -0.17
- Earnings Announcement 2026-05-12 10:59:00
- Shares Outstanding $27,884,955
Company brief: SEASTAR MEDICAL HOLDING CORPORATION (ICU )
- Healthcare
- Biotechnology
- Mr. Eric Schlorff
- https://www.seastarmedical.com
- US
- N/A
- 03-18-2021
- US81256L1044
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
ICU Corporation News
SeaStar Medical Announces Appointment of Michael Messinger as CFO
globenewswire.com -- DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...